Carta al Editor
Barra lateral del artículo
Descargas
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Contenido principal del artículo
Resumen
Carta al Editor
Citas
World Medical Association Declaration of Helsinki. JAMA. 2013;310(20):2191.
Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c869–c869.
Winter K, Pugh SL. An investigator’s introduction to statistical considerations in clinical trials. Urologic Oncology: Seminars and Original Investigations. 2019;37(5):305–12.
Pocock SJ, McMurray JJV, Collier TJ. Statistical controversies in reporting of clinical trials. J Am Coll Cardiol. 2015;66(23):2648-62.
Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: Chance, not choice. Lancet. 2002;359(9305):515-9.
Sedgwick P. Block randomisation. BMJ. 2011;343:1016.
Altman DG, Bland JM. Statistics notes: How to randomise. BMJ. 1999;319(7211):703–4.
Burgess DC, Gebski VJ, Keech AC. Baseline data in clinical trials. Med J Aust. 2003;179(2):105–7.
Pocock SJ, McMurray JJV, Collier TJ. Making sense of statistics in clinical trial reports. J Am Coll Cardiol. 2015;66(22):2536-49.
Yadav K, Lewis RJ. Gatekeeping strategies for avoiding false-positive results in clinical trials with many comparisons. JAMA. 2017;318(14):1385-1386.
Schulz KF, Grimes DA. Multiplicity in randomised trials I: Endpoints and treatments. Lancet. 2005;365(9470):1591-5.
Schober P, Vetter TR. Adjustments for multiple testing in medical research. Anesth Analg. 2020;130(1):99.